iCad (Nasdaq:ICAD) announced today that it entered into a collaboration with Solis Mammography to define cardiovascular risk. The development and commercial collaboration revolves around producing an artificial intelligence (AI) solution. This solution potentially quantifies the presence of breast arterial calcifications in a mammogram to assess the risk of cardiovascular disease (CVD). It uses data obtained […]
Women's Health
Study backs FEMSelect meshless pelvic floor fixation system
FEMSelect announced positive results from a four-year prospective follow-up evaluation of its EnPlace system. Newark, Delaware-based FEMSelect designed its EnPlace system as a minimally invasive, meshless approach to pelvic floor ligament fixation. The device attaches sutures to ligaments of the pelvic floor. It represents an alternative to heavily scrutinized pelvic mesh devices. Medical investigators found […]
J&J settles big Australian pelvic mesh case
Johnson & Johnson (NYSE: JNJ) has settled an Australian pelvic mesh class action suit for AU$300 million (roughly U.S. $205 million), according to media reports. Shine Lawyers, which handled the suit, confirmed the settlement. It still requires court approval. More than 11,000 claimants in Australia had sought relief, according to Reuters. In a statement shared […]
Titan Medical, Medtronic strike development deal on surgical robots
Titan Medical (TSX:TMD;OTC:TITFX) today announced the signing of a new agreement with medtech giant Medtronic (NYSE:MDT). The definitive agreement builds upon a development and license deal agreed in June 2020. Titan achieved all three milestones laid out in the agreement, including raising $18 million in capital in October 2020. It also received a $10 million payment for the second […]
Neuspera Medical appoints new CEO
Implantable neuromodulation technology developer Neuspera Medical announced today that Steffen Hovard joined the company as CEO. Hovard most recently served as president of Coloplast’s interventional urology arm. He had leadership responsibilities across four business areas within urological devices. At Coloplast, he oversaw 900 employees across 19 countries. According to a news release, Hovard also serves […]
Ibex reports positive outcomes for AI-based breast cancer diagnostic
Ibex Medical Analytics announced today that a study of its Galen Breast diagnostic offering delivered positive outcomes. Tel Aviv, Israel-based Ibex designed its Galen platform to support pathologists in diagnosing breast, prostate, and gastric biopsies. Galen uses AI and machine learning technology based on hundreds of thousands of image samples scanned from biopsy slides through […]
Data supports use of Channel Medsystems Cerene cryotherapy
Channel Medsystems announced today that long-term clinical outcomes support its Cerene cryotherapy for treating heavy menstrual bleeding (HMB). Long-term outcomes from the Clarity clinical study evaluating the safety and effectiveness of Cerene cryotherapy were published in the International Journal of Women’s Health. Emeryville, California-based Channel Medsystems designed Cerene as a proprietary, hand-held technology for delivering cryotherapy […]
Nanopath raises $10M Series A for women’s health diagnostics
Nanopath announced that it closed a Series A funding round to support its biosensing platform for diagnostics. Cambridge, Massachusetts–based Nanopath intends to use the funds to back the development and commercialization of its platform that aims to transform how women’s pelvic and gynecologic infections are diagnosed. The company designed its novel approach to simultaneously characterize […]
Axonics expects 40% revenue growth this year
Axonics (Nasdaq:AXNX) shares are on the rise today on second-quarter results that came in ahead of the consensus forecast amid a successful TV advertising campaign. The Irvine, California–based sacral neuromodulation technology developer posted losses of $34.1 million, or 47¢ per share, on sales of $69 million for the three months ended June 30, 2022, for […]
Hologic’s Q3 earnings exceed expectations despite sales slowdown and chip shortage
Hologic (Nasdaq:HOLX) posted third-quarter results today that beat the consensus forecast on Wall Street and increased its outlook for the rest of the year. Marlborough, Massachusetts–based Hologic reported profits of $228.4 million, or $0.90 per share, on sales of $1 billion for the three months ended June 25, 2022. Compared with Q3 2021, profits decreased […]
Coloplast wins summary judgement in transvaginal mesh suit in Minnesota
A federal judge in Minnesota granted summary judgment to Coloplast in a lawsuit over the company’s transvaginal mesh. Angela Dawn Cantrell received the Restorelle L mesh implant as part of surgery to correct vaginal prolapse in January 2018. Cantrell continued to experience pain and pelvic floor dysfunction after the surgery and underwent additional surgeries. In […]